This resource was selected by SMI Adviser content partners and approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.
This large‐scale meta‐analysis confirms that SMI patients have significantly increased risk of cardiovascular disease (CVD) and CVD‐related mortality, and that elevated body mass index, antipsychotic use, and CVD screening and management require urgent clinical attention.